ID: ALA275362

Max Phase: Preclinical

Molecular Formula: C15H13NO3

Molecular Weight: 255.27

Molecule Type: Small molecule

Associated Items:

Representations

Canonical SMILES:  O=C(/C=C/c1ccc(O)c(O)c1)Nc1ccccc1

Standard InChI:  InChI=1S/C15H13NO3/c17-13-8-6-11(10-14(13)18)7-9-15(19)16-12-4-2-1-3-5-12/h1-10,17-18H,(H,16,19)/b9-7+

Standard InChI Key:  WWYUUQYLTXYLBK-VQHVLOKHSA-N

Associated Targets(Human)

HCT-116 91556 Activities

Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID

A-431 6446 Activities

Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID

Protein-tyrosine phosphatase 1B 8528 Activities

Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID

MMP-1/MMP-2 86 Activities

Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID

Matrix metalloproteinase 9 6779 Activities

Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID

Matrix metalloproteinase-2 6627 Activities

Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID

Matrix metalloproteinase-1 7046 Activities

Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID

Associated Targets(non-human)

B16 5829 Activities

Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID

Bacillus subtilis 32866 Activities

Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID

Pseudomonas fluorescens 1630 Activities

Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID

Staphylococcus aureus 210822 Activities

Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID

Candida albicans 78123 Activities

Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID

Tyrosinase 3884 Activities

Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID

Molecule Features

Natural Product: NoOral: NoChemical Probe: NoParenteral: No
Molecule Type: Small moleculeTopical: NoFirst In Class: NoBlack Box: No
Chirality: NoAvailability: NoProdrug: No

Drug Indications

MESH IDMESH Heading EFO IDsEFO TermsMax Phase for IndicationReferences

Mechanisms of Action

Mechanism of ActionAction Typetarget IDTarget NameTarget TypeTarget OrganismBinding Site NameReferences

Properties

Molecular Weight: 255.27Molecular Weight (Monoisotopic): 255.0895AlogP: 2.75#Rotatable Bonds: 3
Polar Surface Area: 69.56Molecular Species: NEUTRALHBA: 3HBD: 3
#RO5 Violations: 0HBA (Lipinski): 4HBD (Lipinski): 3#RO5 Violations (Lipinski): 0
CX Acidic pKa: 9.22CX Basic pKa: CX LogP: 2.96CX LogD: 2.96
Aromatic Rings: 2Heavy Atoms: 19QED Weighted: 0.58Np Likeness Score: -0.13

References

1. Nam NH, You YJ, Kim Y, Hong DH, Kim HM, Ahn BZ..  (2001)  Syntheses of certain 3-aryl-2-propenoates and evaluation of their cytotoxicity.,  11  (9): [PMID:11354370] [10.1016/s0960-894x(01)00165-2]
2. Rajan P, Vedernikova I, Cos P, Berghe DV, Augustyns K, Haemers A..  (2001)  Synthesis and evaluation of caffeic acid amides as antioxidants.,  11  (2): [PMID:11206462] [10.1016/s0960-894x(00)00630-2]
3. Jung M, Lee Y, Park M, Kim H, Kim H, Lim E, Tak J, Sim M, Lee D, Park N, Oh WK, Hur KY, Kang ES, Lee HC..  (2007)  Design, synthesis, and discovery of stilbene derivatives based on lithospermic acid B as potent protein tyrosine phosphatase 1B inhibitors.,  17  (16): [PMID:17596944] [10.1016/j.bmcl.2007.06.016]
4. Fu J, Cheng K, Zhang ZM, Fang RQ, Zhu HL..  (2010)  Synthesis, structure and structure-activity relationship analysis of caffeic acid amides as potential antimicrobials.,  45  (6): [PMID:20181415] [10.1016/j.ejmech.2010.01.066]
5. Shi ZH, Li NG, Shi QP, Tang H, Tang YP, Li W, Yin L, Yang JP, Duan JA..  (2013)  Synthesis and structure-activity relationship analysis of caffeic acid amides as selective matrix metalloproteinase inhibitors.,  23  (5): [PMID:23375794] [10.1016/j.bmcl.2013.01.027]
6. Misra K, Maity HS, Nag A, Sonawane A..  (2016)  Radical scavenging and antibacterial activity of caffemides against gram positive, gram negative and clinical drug resistance bacteria.,  26  (24): [PMID:27865704] [10.1016/j.bmcl.2016.10.089]
7. Jo H, Choi M, Sim J, Viji M, Li S, Lee YH, Kim Y, Seo SY, Zhou Y, Lee K, Kim WJ, Hong JT, Lee H, Jung JK..  (2017)  Synthesis and biological evaluation of caffeic acid derivatives as potent inhibitors of α-MSH-stimulated melanogenesis.,  27  (15): [PMID:28619537] [10.1016/j.bmcl.2017.06.011]
8. Ullah S, Kang D, Lee S, Ikram M, Park C, Park Y, Yoon S, Chun P, Moon HR..  (2019)  Synthesis of cinnamic amide derivatives and their anti-melanogenic effect in α-MSH-stimulated B16F10 melanoma cells.,  161  [PMID:30347330] [10.1016/j.ejmech.2018.10.025]

Source